BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14689584)

  • 1. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?
    Suh J; Rabson AB
    J Cell Biochem; 2004 Jan; 91(1):100-17. PubMed ID: 14689584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
    Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
    Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
    Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
    Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
    PĂ©ant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM
    Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity.
    Floryk D; Huberman E
    Cancer Res; 2005 Dec; 65(24):11588-96. PubMed ID: 16357169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells.
    Christensen MJ; Nartey ET; Hada AL; Legg RL; Barzee BR
    Nutr Cancer; 2007; 58(2):197-204. PubMed ID: 17640166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
    Fahy BN; Schlieman MG; Mortenson MM; Virudachalam S; Bold RJ
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):46-54. PubMed ID: 15791457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
    Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
    Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
    Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
    Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
    Vijayvargia R; May MS; Fondell JD
    Cancer Res; 2007 May; 67(9):4034-41. PubMed ID: 17483314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
    Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.
    Sweeney C; Li L; Shanmugam R; Bhat-Nakshatri P; Jayaprakasan V; Baldridge LA; Gardner T; Smith M; Nakshatri H; Cheng L
    Clin Cancer Res; 2004 Aug; 10(16):5501-7. PubMed ID: 15328189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.